Literature DB >> 25065572

Successful desensitization with anakinra in a case with immediate hypersensitivity reaction.

Sadan Şoyyiğit1, Reşat Kendirlinan2, Omür Aydın2, Gülfem E Çelik2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25065572     DOI： 10.1016/j.anai.2014.06.017

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  6 in total

Review 1.  Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism.

Authors:  Antonio Brucato; Giacomo Emmi; Luca Cantarini; Andrea Di Lenarda; Marco Gattorno; Giuseppe Lopalco; Renzo Marcolongo; Massimo Imazio; Alberto Martini; Domenico Prisco
Journal:  Intern Emerg Med       Date:  2018-04-09       Impact factor: 3.397

Review 2.  [Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection].

Authors:  Valeria Herrera-Lasso Regás; María Teresa Dordal Culla; Ramón Lleonart Bellfill
Journal:  Med Clin (Barc)       Date:  2020-07-09       Impact factor: 1.725

3.  Expedited Desensitization to Canakinumab.

Authors:  Neha Sanan; Jason Schend; Marija Rowane; Robert Hostoffer
Journal:  Allergy Rhinol (Providence)       Date:  2020-06-22

Review 4.  Desensitization to biological agents used in rheumatology.

Authors:  Joanna Makowska; Anna Lewandowska-Polak
Journal:  Reumatologia       Date:  2020-02-28

5. 

Authors:  Askin Gülsen; Bettina Wedi; Uta Jappe
Journal:  Allergo J       Date:  2020-06-24

6.  Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper.

Authors:  Aslı Gelincik; Knut Brockow; Gülfem E Çelik; Inmaculada Doña; Cristobalina Mayorga; Antonino Romano; Özge Soyer; Marina Atanaskovic-Markovic; Annick Barbaud; Maria Jose Torres
Journal:  Allergy       Date:  2020-07-01       Impact factor: 14.710
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.